Jean-Luc Balligand
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (NCT02599480) | Jean-Luc Balligand | 2016-09-12 |
Track Jean-Luc Balligand automatically
Every clearance here is in the API, with alerts when new ones post.